Holen Sie sich die Stockscreener-App
19.05
1.76%
0.33
Schlusskurs vom Vortag:
$18.72
Offen:
$18.65
24-Stunden-Volumen:
60,476
Relative Volume:
0.76
Marktkapitalisierung:
$396.60M
Einnahmen:
$-609.47M
Nettoeinkommen (Verlust:
$-937.91M
KGV:
-0.6358
EPS:
-29.96
Netto-Cashflow:
$96.09M
1W Leistung:
+6.60%
1M Leistung:
+8.73%
6M Leistung:
+37.25%
1J Leistung:
+54.00%
1-Tages-Spanne:
$18.65
$20.45
1-Wochen-Bereich:
$17.84
$19.03
52-Wochen-Spanne:
$10.92
$24.59
Shoulder Innovations Inc Stock (SI) Company Profile
Firmenname
Shoulder Innovations Inc
Sektor
Branche
Telefon
616-566-0286
Adresse
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
19.05 | 396.60M | -609.47M | -937.91M | 96.09M | -29.96 |
ABT
Abbott Laboratories
|
98.70 | 170.80B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.48 | 119.57B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.99 | 113.15B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.20 | 64.05B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.80 | 50.61B | 6.30B | 1.07B | 1.09B | 1.8406 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-28 | Eingeleitet | UBS | Buy |
| 2025-08-25 | Eingeleitet | BTIG Research | Buy |
| 2025-08-25 | Eingeleitet | Goldman | Buy |
| 2025-08-25 | Eingeleitet | Jefferies | Buy |
| 2025-08-25 | Eingeleitet | Piper Sandler | Overweight |
| 2023-03-06 | Herabstufung | Compass Point | Neutral → Sell |
| 2023-03-06 | Herabstufung | Wedbush | Neutral → Underperform |
| 2023-03-02 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | Herabstufung | Compass Point | Buy → Neutral |
| 2023-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-03-01 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-01-06 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-01-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-12 | Bestätigt | Wedbush | Outperform |
| 2022-12-05 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-10-26 | Herabstufung | Goldman | Buy → Neutral |
| 2022-10-06 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | Eingeleitet | BTIG Research | Buy |
| 2022-06-13 | Eingeleitet | Wells Fargo | Overweight |
| 2022-06-09 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-03-21 | Eingeleitet | BofA Securities | Buy |
| 2022-01-20 | Hochstufung | Goldman | Neutral → Buy |
| 2021-12-16 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-11-08 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-06-14 | Eingeleitet | Goldman | Neutral |
| 2021-01-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-12-22 | Eingeleitet | Wedbush | Outperform |
| 2020-12-17 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | Eingeleitet | Craig Hallum | Buy |
| 2020-10-16 | Eingeleitet | Compass Point | Buy |
| 2020-03-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | Eingeleitet | Barclays | Overweight |
| 2019-11-18 | Eingeleitet | Compass Point | Buy |
Alle ansehen
Shoulder Innovations Inc Aktie (SI) Neueste Nachrichten
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026 - AOL.com
Transcript: Shoulder Innovations Q2 2026 Earnings Conference Call - Benzinga
Form 4 Shoulder Innovations Inc For: 11 October By Investing.com - Investing.com South Africa
Shoulder Innovations launches limited release o... - Pluang
Shoulder Innovations begins limited release of InSet Go glenoid implant - StreetInsider
Shoulder Innovations Initiates Commercial Launch of the InSet® Go - PR Newswire
A new shoulder implant was used in its first operation. Its design cuts surgical steps. - Stock Titan
Shoulder Innovations Initiates Commercial Launch of the InSet® Go - TradingView
Form 4 Shoulder Innovations Inc For: 7 October By Investing.com - Investing.com Nigeria
Director fees become a 669-unit stock award at Shoulder Innovations (SI). - Stock Titan
Stock replaces cash fees as Shoulder Innovations (SI) awards Paul Buckman 1,275 stock units. - Stock Titan
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook - Lelezard
Shoulder Innovations, Inc.(NYSE: SI) added to S&P Global BMI Index - marketscreener.com
Shoulder Innovations breaks ground on new headquarters as sales surge - Crain's Grand Rapids Business
Shoulder Innovations Partners with ALM Ortho on Bespoke Titanium Implants for Complex Shoulder Cases - 3D Printing Industry
Shareholder plans $187,706 stock sale in Shoulder Innovations (SI) - Stock Titan
Shoulder Innovations moving headquarters to Byron Township - Newsradio WOOD 1300 and 106.9 FM
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - WOODTV.com
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - WOODTV.com
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - Yahoo Finance
Kerry Olin Appointed Chief People Officer at Shoulder Innovations - hrtoday.in
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com South Africa
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com Nigeria
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com Canada
Shoulder Innovations receives FDA clearance for titanium implant - investing.com
Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch - TradingView
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com UK
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - PR Newswire
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - Yahoo Finance
About 10% to 15% of people test positive for metal sensitivity. Shoulder Innovations launches an implant. - Stock Titan
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - Ortho Spine News
Shoulder Innovations partners with ALM Ortho on implants - investing.com
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - STLtoday.com
Catalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder Innovations - Business Wire
Silvergate ex-CEO blames Biden pressure for bank’s 2023 wind-down - Crypto Briefing
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - PR Newswire
Shoulder Innovations Collaborates With ALM Ortho to Introduce Implant for Shoulder Deformity - Yahoo Finance
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - Yahoo Finance
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - Ortho Spine News
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com India
Shoulder Innovations Settles Patent Dispute With Catalyst OrthoScience - marketscreener.com
Shoulder Innovations settles patent dispute with Catalyst - investing.com
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com Canada
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com UK
Shoulder Innovations Announces Settlement of - Moomoo
A patent fight over shoulder surgery ends in settlement. Terms remain confidential. - Stock Titan
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - PR Newswire
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com South Africa
Shoulder Innovations (SI) Advances 2.75% as Shares Approach Resistance at $22.17Time Weighted Price - dars.gov.et
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference - Morningstar
Finanzdaten der Shoulder Innovations Inc-Aktie (SI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Shoulder Innovations Inc-Aktie (SI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ROBERT BALL | Officer |
Sep 14 '26 |
Proposed Sale |
18.45 |
10,175 |
187,706 |
0 |
| Ball Robert Joseph | CEO & Executive Chairman |
Sep 14 '26 |
Sale |
18.45 |
10,175 |
187,706 |
380,824 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 26 '26 |
Sale |
22.60 |
1,196 |
27,030 |
2,185,914 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 24 '26 |
Sale |
22.62 |
681 |
15,404 |
2,187,110 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 21 '26 |
Sale |
22.61 |
20,516 |
463,867 |
2,187,791 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 20 '26 |
Sale |
22.60 |
3,900 |
88,140 |
2,208,307 |
| Ahearn Matthew Fraser | Chief Operating Officer |
Aug 18 '26 |
Sale |
20.99 |
14,186 |
297,704 |
244,176 |
| Ahearn Matthew Fraser | Chief Operating Officer |
Aug 17 '26 |
Sale |
20.10 |
8,314 |
167,101 |
258,362 |
| MATTHEW AHEARN | Director |
Aug 17 '26 |
Proposed Sale |
20.73 |
22,500 |
466,425 |
0 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 06 '26 |
Sale |
22.60 |
2,095 |
47,347 |
2,212,207 |
0.41%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):